TODD STRATEGY GROUP

Lobbying for GENMAB · Biotech company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate · $60,000.00 income · posted Oct 12, 2025

Lobbying activity 2

Health Issues

Prescription Drug Pricing. Implementation of Inflation Reduction Act of 2022.

Medicare/Medicaid

General Medicare/Medicaid Issues. 340B Issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.